PARP1 and posterior cortical atrophy: When PARP inhibition was tested as a potential enhancer of radiotherapy in PCa using either siRNA against PARP1 or nicotinamide (a non-selective PARP inhibitor), recruitment of both SMARCA5 and, to a lesser extent, SMARCD1 was inhibited [108].